Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

被引：0
|
作者：
Toshihiko Arizumi
Susumu Tazuma
Hiroyuki Isayama
Takahiro Nakazawa
Toshio Tsuyuguchi
Hajime Takikawa
Atsushi Tanaka
机构：
[1] Teikyo University School of Medicine,Department of Medicine
[2] Hiroshima University,Department of General Internal Medicine, Graduate School of Biomedical & Health Sciences
[3] Juntendo University,Department of Gastroenterology, Graduate School of Medicine
[4] Nagoya City University,Department of Gastroenterology
[5] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[6] Teikyo University,Faculty of Medical Technology
来源：
Journal of Gastroenterology | 2022年 / 57卷
关键词：
Ursodeoxycholic acid; Long-term outcomes; Primary sclerosing cholangitis; Liver transplantation-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：902 / 912
页数：10
相关论文
共 50 条
  • [1] Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis
    Arizumi, Toshihiko
    Tazuma, Susumu
    Isayama, Hiroyuki
    Nakazawa, Takahiro
    Tsuyuguchi, Toshio
    Takikawa, Hajime
    Tanaka, Atsushi
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (11) : 902 - 912
  • [2] Long-Term Outcome of Gallbladder Polyps in Patients With Primary Sclerosing Cholangitis
    Treeprasertsuk, Sombat
    Sinakos, Emmanouil
    Keach, Jill C.
    Lindor, Keith D.
    GASTROENTEROLOGY, 2010, 138 (05) : S787 - S787
  • [3] The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis
    Navaneethan, U.
    Venkatesh, P. G. K.
    Lashner, B. A.
    Shen, B.
    Kiran, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (09) : 1045 - 1053
  • [4] URSODEOXYCHOLIC ACID FOR PRIMARY SCLEROSING CHOLANGITIS
    CHAZOUILLERES, O
    POUPON, R
    CAPRON, JP
    METMAN, EH
    DHUMEAUX, D
    AMOURETTI, M
    COUZIGOU, P
    LABAYLE, D
    TRINCHET, JC
    JOURNAL OF HEPATOLOGY, 1990, 11 (01) : 120 - 123
  • [5] OUTCOME OF PRIMARY SCLEROSING CHOLANGITIS - ANALYSIS OF LONG-TERM OBSERVATION OF 38 PATIENTS
    LEBOVICS, E
    PALMER, M
    WOO, J
    SCHAFFNER, F
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) : 729 - 731
  • [6] Ursodeoxycholic acid in primary sclerosing cholangitis
    Triantos, C. K.
    Koukias, N.
    Nikolopoulou, V.
    Burroughs, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (05) : 622 - 623
  • [7] Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement
    Catanzaro, E.
    Peviani, M.
    Perin, N.
    Bonaiuto, E.
    Simionato, F.
    Motta, R.
    Gambato, M.
    Floreani, A.
    Cazzagon, N.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S59 - S60
  • [8] EFFECT OF URSODEOXYCHOLIC ACID WITHDRAWAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Wunsch, E.
    Trottier, J.
    Barbier, O.
    Milkiewicz, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S396 - S396
  • [9] Primary sclerosing cholangitis: Conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid
    vonSchonfeld, J
    Zotz, R
    Mahl, M
    Beste, M
    Breuer, N
    Goebell, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (02): : 123 - 127
  • [10] Long-term follow-up of a multicenter, randomized controlled trial of ursodeoxycholic acid in primary sclerosing cholangitis
    Hilscher, Moira
    Tabibian, James H.
    Enders, Felicity B.
    Carey, Elizabeth J.
    Lindor, Keith D.
    HEPATOLOGY, 2015, 62 : 509A - 509A
12345